v3.26.1
Equity (Tables)
6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Schedule of Share Capital Activity

Share capital activity was as follows (in thousands of shares of NIS 5 par value per share):

 

 

Ordinary shares

 

 

2026

 

 

2025

 

Shares outstanding as of January 1

 

 

206,812

 

 

 

215,777

 

Exercise of share options and vesting of RSUs during the period

 

 

3,073

 

 

 

2,585

 

Share issuance as part of settlement

 

 

704

 

 

 

 

Shares outstanding as of June 30

 

 

210,589

 

 

 

218,362

 

 

Schedule of Stock Option Activity and Related Information

A summary of the Company’s stock option activity and related information is as follows:

 

 

Number
of options

 

 

Weighted
average
exercise price

 

 

Weighted
average
intrinsic value

 

Outstanding on December 31, 2025

 

 

298,334

 

 

$

3.57

 

 

$

0.02

 

Granted

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

Forfeited and expired

 

 

 

 

 

 

 

 

 

Outstanding on June 30, 2026

 

 

298,334

 

 

 

3.57

 

 

 

0.02

 

Exercisable as of June 30, 2026

 

 

290,834

 

 

 

3.59

 

 

 

0.02

 

Schedule of Companies RSU Activity

A summary of the Company’s RSU activity is as follows:

 

 

 

 

 

Weighted

 

 

 

 

 

average

 

 

Number of Units

 

 

grant price

 

Outstanding on December 31, 2025

 

 

6,222,034

 

 

$

1.86

 

Granted

 

 

1,242,256

 

 

 

1.57

 

Vested

 

 

(3,073,306

)

 

 

1.88

 

Forfeited

 

 

(977,980

)

 

 

2.08

 

Outstanding on June 30, 2026

 

 

3,413,004

 

 

$

1.71

 

Schedule of Companies Warrants Activity and Related Information

A summary of the Company’s warrants activity and related information is as follows:

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

average

 

 

 

 

 

 

Weighted

 

 

remaining

 

 

 

 

 

 

average

 

 

contractual

 

 

 

 

 

 

exercise

 

 

life (in

 

 

 

Warrants

 

 

price

 

 

years)

 

Outstanding on December 31, 2025

 

 

29,242,103

 

 

$

5.96

 

 

 

1.60

 

Granted

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

Expired

 

 

 

 

 

 

 

 

 

Outstanding and exercisable as of June 30, 2026

 

 

29,242,103

 

 

$

5.96

 

 

 

1.60

 

 

Schedule of Stock Based Compensation Expense Related to Stock Options RSU and Warrants

Stock-based compensation expense related to stock options and RSUs is included in the condensed consolidated statements of operations and comprehensive loss as follows:

 

 

 

Three months ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Cost of revenue

 

$

105

 

 

$

80

 

 

$

263

 

 

$

326

 

Research and development expenses

 

 

(46

)

 

 

644

 

 

 

432

 

 

 

713

 

Sales and marketing expenses

 

 

119

 

 

 

225

 

 

 

319

 

 

 

548

 

General and administrative expenses

 

 

695

 

 

 

1,480

 

 

 

2,784

 

 

 

57

 

 

$

873

 

 

$

2,429

 

 

$

3,798

 

 

$

1,644